Cannabidiol Modulates Hippocampal Glutamate Function
A single dose of cannabidiol hippocampal glutamate modulation reduced abnormal brain activity during memory tasks in people at clinical high risk for psychosis. This suggests cannabidiol may normalize glutamate signaling in brain regions critical for…
Cannabis Balms for AIMSS: Clinical Trial Evidence
A small clinical trial found topical cannabis balms safe and feasible for women with breast cancer experiencing aromatase inhibitor joint pain. The study shows cannabinoid products are tolerated by this population. Larger trials are needed to confirm…
Cannabinoid Drug Interactions: Clinical Evidence Review
Cannabinoid drug interactions are an important consideration in clinical care. This review summarizes clinical evidence on how cannabinoids, especially CBD, interact with medications metabolized by cytochrome P450 enzymes. Understanding these…
Cannabinoid Pain Relief: Evidence-Based Clinical Review
Clinical Takeaway Clinical Takeaway Cannabinoids directly affect sodium channels involved in pain signal transmission in nerves, which provides a potential mechanism for their analgesic effects. This systematic review consolidates evidence that…
Research on Maternal Cannabis Use and Pregnancy Risks
Maternal cannabis use pregnancy risks research highlights associations with increased autism and ADHD risks in children. Cannabis crosses the placental barrier affecting fetal brain development. Pregnant patients should be informed about these…
Clinical Research on Cannabis Derivatives for Autism
Cannabis derivatives autism clinical trials indicate potential benefits for behavioral challenges and anxiety in autism spectrum disorder. Current evidence is limited by small sample sizes and varied outcome measures. Larger randomized controlled trials…
Understanding Internalising Symptoms and Cannabis Use Risk in Adolescents
Internalising symptoms cannabis use risk adolescents is a critical area of study in adolescent mental health. Adolescents with untreated anxiety and depression symptoms show increased risk for cannabis use initiation. Early intervention targeting these…
Endocannabinoid System & Adolescent Psychotic Disorder Risk
Adolescent cannabis use psychotic disorder risk is a growing concern with evidence linking cannabis exposure to increased psychiatric disorders. This risk spans psychotic, bipolar, depressive, and anxiety disorders. Understanding these associations is…
Clinical Research on Endocannabinoid System and Psychosis
Endocannabinoid system psychosis research provides critical clinical evidence for understanding first episode psychosis. This research highlights correlations between symptom severity and substance use. Early intervention informed by this research may…
Clinical Insights from the AURORA Study on Insomnia and Cannabis Use
The aurora study insomnia cannabis research highlights how pre-trauma insomnia predicts increased cannabis use after trauma. This clinical research emphasizes the need for monitoring trauma survivors with sleep disturbances. Early insomnia management may…